NLTX Historical PE Ratio image   This NLTX PE ratio history page last updated 8/11/2022
NLTX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/9/2022
0.98-0.28-1.12NA
Q1 2022
5/9/2022
1.14-0.28-1.12NA
Q4 2021
3/1/2022
2.54-0.27-1.08NA
Q3 2021
11/4/2021
7.44-0.28-1.12NA
Q2 2021
8/5/2021
7.50-0.27-1.08NA
Q1 2021
5/12/2021
10.68-0.27-1.08NA
Q4 2020
3/25/2021
11.68-0.23-0.92NA
Q3 2020
11/9/2020
11.60-0.19-0.76NA
Q2 2020
8/12/2020
11.99-0.20-0.80NA
Q1 2020
5/6/2020
12.50-0.18-0.72NA
Q4 2019
3/12/2020
7.53-0.06-0.24NA
Q3 2019
11/13/2019
2.92-0.44-1.76NA
Q2 2019
7/31/2019
2.670.000.00NA
Q1 2019
5/7/2019
2.68-0.09-0.36NA
Q4 2018
3/7/2019
2.67-0.20-0.80NA
Q3 2018
11/7/2018
2.53-0.64-2.56NA
Q2 2018
8/8/2018
3.040.120.486.3
Q1 2018
5/8/2018
13.11-0.62-2.48NA
Q4 2017
3/12/2018
16.37-0.69-2.76NA
Q3 2017
11/8/2017
11.07-0.50-2.00NA
Q2 2017
8/8/2017
14.26-0.59-2.36NA
Q1 2017
5/9/2017
14.89-0.36-1.44NA
Q4 2016
3/9/2017
17.43-0.48-1.92NA
Q3 2016
11/9/2016
12.62-0.46-1.84NA
Q2 2016
8/4/2016
9.61-0.63-2.52NA
Q1 2016
5/10/2016
7.11-0.39-1.56NA
Q4 2015
3/14/2016
8.43-0.27-1.08NA
Q3 2015
11/10/2015
13.56-0.43-1.72NA
Q2 2015
8/6/2015
1.79-0.44-1.76NA
Q1 2015
5/12/2015
7.78-0.60-2.40NA
NLTX PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/9/2022
0.98-0.28-0.83NA
Q1 2022
5/9/2022
1.14-0.28-0.83NA
Q4 2021
3/1/2022
2.54-0.27-1.09NA
Q3 2021
11/4/2021
7.44-0.28-1.05NA
Q2 2021
8/5/2021
7.50-0.27-0.96NA
Q1 2021
5/12/2021
10.68-0.27-0.89NA
Q4 2020
3/25/2021
11.68-0.23-0.80NA
Q3 2020
11/9/2020
11.60-0.19-0.63NA
Q2 2020
8/12/2020
11.99-0.20-0.88NA
Q1 2020
5/6/2020
12.50-0.18-0.68NA
Q4 2019
3/12/2020
7.53-0.06-0.59NA
Q3 2019
11/13/2019
2.92-0.44-0.73NA
Q2 2019
7/31/2019
2.670.00-0.93NA
Q1 2019
5/7/2019
2.68-0.09-0.81NA
Q4 2018
3/7/2019
2.67-0.20-1.34NA
Q3 2018
11/7/2018
2.53-0.64-1.83NA
Q2 2018
8/8/2018
3.040.12-1.69NA
Q1 2018
5/8/2018
13.11-0.62-2.40NA
Q4 2017
3/12/2018
16.37-0.69-2.14NA
Q3 2017
11/8/2017
11.07-0.50-1.93NA
Q2 2017
8/8/2017
14.26-0.59-1.89NA
Q1 2017
5/9/2017
14.89-0.36-1.93NA
Q4 2016
3/9/2017
17.43-0.48-1.96NA
Q3 2016
11/9/2016
12.62-0.46-1.75NA
Q2 2016
8/4/2016
9.61-0.63-1.72NA
Q1 2016
5/10/2016
7.11-0.39-1.53NA
Q4 2015
3/14/2016
8.43-0.27-1.74NA
Q3 2015
11/10/2015
13.56-0.43NANA
Q2 2015
8/6/2015
1.79-0.44NANA
Q1 2015
5/12/2015
7.78-0.60NANA
Quotes delayed 20 minutes

Email EnvelopeFree NLTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Neoleukin Therapeutics (NLTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

NMTC PE Ratio History
NMTR PE Ratio History
NOTV PE Ratio History
NOVN PE Ratio History
NPCE PE Ratio History
NRBO PE Ratio History
NRC PE Ratio History
NRIX PE Ratio History
NSTG PE Ratio History
NTLA PE Ratio History
How should the NLTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Neoleukin Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this NLTX Historical PE Ratio page.

What is the average historical PE for NLTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The NLTX historical PE ratio using the annualized quarterly earnings method works out to 6.3.

What is the average historical PE for NLTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The NLTX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the NLTX Historical PE Ratio information for Neoleukin Therapeutics' stock. The average NLTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 6.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NLTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NLTX historical PE result, against the recent PE: when this page was posted on 8/10/2022, the most recent closing price for NLTX had been 0.98, and the most recent quarterly earnings result, annualized, was 0.48. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent NLTX PE on 8/10/2022 based on annualized quarterly EPS was 2.0. Based on NLTX's history, that recent PE is low relative to the historical average, with the recent PE 68.3% lower than the historical average PE across our data set for Neoleukin Therapeutics.

For self directed investors doing their due diligence on NLTX or any other given stock, valuation analysis for NLTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Neoleukin Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NLTX. Thanks for visiting, and the next time you need to research NLTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding IRCP, BRZS Videos, EXPD shares outstanding history.

 

NLTX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.